文献速递其他结缔组织病

美国成人皮肌炎住院负担的预测因素:住院率、住院时长与费用

Predictors of Hospitalization, Length of Stay, and Cost of Care Among Adults With Dermatomyositis in the United States.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2017-08-08

该研究分析2002—2012年美国全国住院样本中72,651,487例住院记录,评估皮肌炎患者住院率、住院时长及费用的预测因素。结果显示女性、非白种族及多种慢性病与皮肌炎住院率升高相关,非白人种族与住院时长和费用增加相关,皮肌炎住院负担显著且呈上升趋势。

要点

  • 女性、非白人种族及多种慢性病与皮肌炎住院率升高独立相关。
  • 皮肌炎患者住院时长和费用显著高于无皮肌炎患者。
  • 非白人种族与住院时长和费用增加相关。

核心结论

  • 美国皮肌炎住院负担显著且不断增加,非白人患者住院率、住院时长和费用更高。

研究设计与样本

  • 基于2002—2012年美国全国住院样本(Nationwide Inpatient Sample)中72,651,487例住院记录的分析。

主要发现

  • 原发性或继发性皮肌炎诊断的加权住院分别为9,687例和43,188例。
  • 女性(aOR 2.05,95%CI 1.80–2.34)、非白人种族及多种慢性病与皮肌炎住院率升高相关。
  • 非白人种族与住院时长增加(非裔美国人β 0.14,95%CI 0.04–0.25;亚裔β 0.38,95%CI 0.22–0.55)和费用增加(亚裔β 0.51,95%CI 0.36–0.67)相关。

关键数值与推荐

  • 女性aOR 2.05(95%CI 1.80–2.34);非裔美国人aOR 1.68(95%CI 1.57–1.79);西班牙裔aOR 2.38(95%CI 2.22–2.55);亚裔aOR 1.54(95%CI 1.32–1.81);多种族/其他aOR 1.65(95%CI 1.45–1.88)。
  • 慢性病2–5种aOR 2.39(95%CI 2.20–2.60),≥6种aOR 2.80(95%CI 2.56–3.07)。
  • 原发性皮肌炎住院加权总住院时长为80,686天,总费用为$168,076,970,几何均值分别为5.38天(95%CI 5.08–5.71)和$11,682(95%CI $11,013–$12,392)。

临床怎么用

  • 临床应关注女性、非白人种族及合并多种慢性病的皮肌炎患者,其住院风险更高。
  • 非白人皮肌炎患者住院时长和费用更高,需优化资源分配与出院规划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the prevalence and risk factors for hospitalization with dermatomyositis and assess inpatient burden of dermatomyositis. METHODS: Data on 72,651,487 hospitalizations from the 2002-2012 Nationwide Inpatient Sample, a 20% stratified sample of all acute-care hospitalizations in the US, were analyzed. International Classification of Diseases, Ninth Revision, Clinical Modification coding was used to identify hospitalizations with a diagnosis of dermatomyositis. RESULTS: There were 9,687 and 43,188 weighted admissions with a primary or secondary diagnosis of dermatomyositis, respectively. In multivariable logistic regression models with stepwise selection, female sex (logistic regression: adjusted odds ratio 2.05 [95% confidence interval (95% CI) 1.80, 2.34]), nonwhite race (African American: 1.68 [1.57, 1.79]; Hispanic: 2.38 [2.22, 2.55]; Asian: 1.54 [1.32, 1.81]; and multiracial/other: 1.65 [1.45, 1.88]), and multiple chronic conditions (2-5: 2.39 [2.20, 2.60] and ≥6: 2.80 [2.56, 3.07]) were all associated with higher rates of hospitalization for dermatomyositis. The weighted total length of stay (LOS) and inflation-adjusted cost of care for patients with a primary inpatient diagnosis of dermatomyositis was 80,686 days and $168,076,970, with geometric means of 5.38 (95% CI 5.08, 5.71) and $11,682 (95% CI $11,013, $12,392), respectively. LOS and costs of hospitalization were significantly higher in patients with dermatomyositis compared to those without. Notably, race/ethnicity was associated with increased LOS (log-linear regression: adjusted β [95% CI] for African American: 0.14 [0.04, 0.25] and Asian: 0.38 [0.22, 0.55]) and cost of care (Asian: 0.51 [0.36, 0.67]). CONCLUSION: There is a significant and increasing inpatient burden for dermatomyositis in the US. There appear to be racial differences, as nonwhites have higher prevalence of admission, increased LOS, and cost of care.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Kwa MC, Ardalan K, Laumann AE, et al. Predictors of Hospitalization, Length of Stay, and Cost of Care Among Adults With Dermatomyositis in the United States. Arthritis Care Res (Hoboken). 2017. PMID: 28556622. doi:10.1002/acr.23190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。